P-017: POINT-OF-CARE DIAGNOSTIC FOR QUANTIFICATION OF FOETAL HAEMOGLOBIN (HB F) LEVELS IN MONITORING HYDROXYUREA THERAPY FOR CHILDREN WITH SICKLE CELL DISEASE (SCD) IN GHANA

por C., SEGBEFIA, Y., DEI-ADOMAKOH, E., MENSAH, P., THOTA, I., ODAME
Publicado 2022

P-003: EVALUATION OF TREATMENT PATTERN, HEALTHCARE RESOURCE UTILIZATION AND COSTS OF ILLNESS FOR SICKLE CELL DISEASE IN GHANA: A PRIVATE MEDICAL INSURANCE CLAIMS DATABASE STUDY

por Y., DEI-ADOMAKOH, C., SEGBEFIA, D., DWOMOH, K., MARFO, A., EDGAL, O., EGBUJO, K., ATAGA
Publicado 2022

P-047: PROSPECTIVE IDENTIFICATION OF VARIABLES AS OUTCOMES FOR TREATMENT (PIVOT): A PHASE II CLINICAL TRIAL OF HYDROXYUREA FOR CHILDREN AND ADULTS WITH HBSC DISEASE

por L., SMART, C., SEGBEFIA, T., LATHAM, S., STUBER, K., AMISSAH-ARTHUR, A., LANE, Y., DEI-ADOMAKOH, R., WARE
Publicado 2022

P-002: MULTISPECTRAL IMAGING FOR MICROCHIP ELECTROPHORESIS ENABLES POINT-OF-CARE NEWBORN HEMOGLOBIN VARIANT SCREENING

por R., AN, Y., HUANG, A., ROCHELEAU, A., AVANAKI, P., THOTA, Q., ZHANG, Y., MAN, Z., SEKYONDA, C., SEGBEFIA, Y., DEI-ADOMAKOH, E., MENSAH, K., OHENE-FREMPONG, I., ODAME, A., OWUSU-ANSAH, U., GURKAN
Publicado 2022